Correlation Between GlaxoSmithKline PLC and FnGuide

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both GlaxoSmithKline PLC and FnGuide at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining GlaxoSmithKline PLC and FnGuide into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between GlaxoSmithKline PLC ADR and FnGuide, you can compare the effects of market volatilities on GlaxoSmithKline PLC and FnGuide and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in GlaxoSmithKline PLC with a short position of FnGuide. Check out your portfolio center. Please also check ongoing floating volatility patterns of GlaxoSmithKline PLC and FnGuide.

Diversification Opportunities for GlaxoSmithKline PLC and FnGuide

0.18
  Correlation Coefficient

Average diversification

The 3 months correlation between GlaxoSmithKline and FnGuide is 0.18. Overlapping area represents the amount of risk that can be diversified away by holding GlaxoSmithKline PLC ADR and FnGuide in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on FnGuide and GlaxoSmithKline PLC is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on GlaxoSmithKline PLC ADR are associated (or correlated) with FnGuide. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of FnGuide has no effect on the direction of GlaxoSmithKline PLC i.e., GlaxoSmithKline PLC and FnGuide go up and down completely randomly.

Pair Corralation between GlaxoSmithKline PLC and FnGuide

Considering the 90-day investment horizon GlaxoSmithKline PLC ADR is expected to generate 0.69 times more return on investment than FnGuide. However, GlaxoSmithKline PLC ADR is 1.46 times less risky than FnGuide. It trades about -0.33 of its potential returns per unit of risk. FnGuide is currently generating about -0.59 per unit of risk. If you would invest  3,731  in GlaxoSmithKline PLC ADR on August 25, 2024 and sell it today you would lose (361.00) from holding GlaxoSmithKline PLC ADR or give up 9.68% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy95.65%
ValuesDaily Returns

GlaxoSmithKline PLC ADR  vs.  FnGuide

 Performance 
       Timeline  
GlaxoSmithKline PLC ADR 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days GlaxoSmithKline PLC ADR has generated negative risk-adjusted returns adding no value to investors with long positions. Despite uncertain performance in the last few months, the Stock's basic indicators remain quite persistent which may send shares a bit higher in December 2024. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.
FnGuide 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in FnGuide are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, FnGuide sustained solid returns over the last few months and may actually be approaching a breakup point.

GlaxoSmithKline PLC and FnGuide Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with GlaxoSmithKline PLC and FnGuide

The main advantage of trading using opposite GlaxoSmithKline PLC and FnGuide positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if GlaxoSmithKline PLC position performs unexpectedly, FnGuide can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in FnGuide will offset losses from the drop in FnGuide's long position.
The idea behind GlaxoSmithKline PLC ADR and FnGuide pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.

Other Complementary Tools

Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios